thiophenes has been researched along with sulfamic acid in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brechue, WF; Maren, TH | 1 |
| Supuran, CT | 1 |
| Du, Y; Zhang, Y | 1 |
| Afridi, S; Amjad, ST; Anbar, HS; El-Gamal, MI; El-Gamal, R; Iqbal, J; Shafique, Z; Zaib, S; Zaraei, SO | 1 |
| Al-Rashida, M; Anbar, HS; El-Gamal, MI; El-Gamal, R; Iqbal, J; Pelletier, J; Sévigny, J; Ullah, S; Zaib, S; Zaraei, SO | 1 |
2 review(s) available for thiophenes and sulfamic acid
| Article | Year |
|---|---|
Drug interaction considerations in the therapeutic use of carbonic anhydrase inhibitors.
Topics: Acetazolamide; Anti-Inflammatory Agents, Non-Steroidal; Anti-Obesity Agents; Antibodies, Monoclonal; Anticonvulsants; Antineoplastic Agents; Benzodiazepines; Carbonic Anhydrase Inhibitors; Celecoxib; Clinical Trials as Topic; Contraindications; Drug Interactions; Drug-Related Side Effects and Adverse Reactions; Fructose; Humans; Isoxazoles; Methazolamide; Phenobarbital; Sulfanilamide; Sulfanilamides; Sulfonamides; Sulfonic Acids; Thiazines; Thiophenes; Topiramate; Zonisamide | 2016 |
The development of protein tyrosine phosphatase1B inhibitors defined by binding sites in crystalline complexes.
Topics: Benzoic Acid; Binding Sites; Drug Design; Enzyme Inhibitors; Humans; Molecular Docking Simulation; Protein Tyrosine Phosphatase, Non-Receptor Type 1; Structure-Activity Relationship; Sulfonic Acids; Thiophenes | 2018 |
3 other study(ies) available for thiophenes and sulfamic acid
| Article | Year |
|---|---|
Carbonic anhydrase inhibitory activity and ocular pharmacology of organic sulfamates.
Topics: Animals; Carbonic Anhydrase Inhibitors; Eye; Hydrogen-Ion Concentration; Imidazoles; Intraocular Pressure; Rabbits; Structure-Activity Relationship; Sulfonamides; Sulfonic Acids; Thiophenes | 1993 |
Sulfonate and sulfamate derivatives possessing benzofuran or benzothiophene nucleus as potent carbonic anhydrase II/IX/XII inhibitors.
Topics: Benzofurans; Carbonic Anhydrase Inhibitors; Carbonic Anhydrases; Dose-Response Relationship, Drug; HEK293 Cells; Humans; Isoenzymes; Molecular Docking Simulation; Molecular Structure; Structure-Activity Relationship; Sulfonic Acids; Thiophenes | 2019 |
Evaluation of sulfonate and sulfamate derivatives possessing benzofuran or benzothiophene nucleus as inhibitors of nucleotide pyrophosphatases/phosphodiesterases and anticancer agents.
Topics: Antineoplastic Agents; Benzofurans; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Enzyme Inhibitors; Humans; Molecular Docking Simulation; Molecular Structure; Phosphoric Diester Hydrolases; Pyrophosphatases; Structure-Activity Relationship; Sulfonic Acids; Thiophenes; Tumor Cells, Cultured | 2020 |